Michela Salvatici
MultiMedica(IT)
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, Acute Myocardial Infarction Research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation(2010)631 cited
- → N-Terminal Pro-B-Type Natriuretic Peptide after High-Dose Chemotherapy: A Marker Predictive of Cardiac Dysfunction?(2005)244 cited
- → Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial(2018)229 cited
- → Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy(2017)92 cited
- → Association between cardiac troponin I and mortality in patients with COVID-19(2020)46 cited
- → Role of biomarkers in cardioncology(2011)44 cited
- → Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin(2020)38 cited
- → Cardiac Complications of Chemotherapy: Role of Biomarkers(2014)32 cited
- → SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy(2021)27 cited
- → Circulating Biomarkers and Cardiac Function Over 3 Years After Chemotherapy with Anthracyclines: The ICOS-ONE Trial(2020)23 cited